Free Trial

Penumbra (PEN) Competitors

Penumbra logo
$239.63 -0.76 (-0.32%)
Closing price 03:59 PM Eastern
Extended Trading
$240.00 +0.38 (+0.16%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PEN vs. LNTH, ITGR, GEHC, PHG, ZBH, SNN, SOLV, STVN, GKOS, and BLCO

Should you be buying Penumbra stock or one of its competitors? The main competitors of Penumbra include Lantheus (LNTH), Integer (ITGR), GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Solventum (SOLV), Stevanato Group (STVN), Glaukos (GKOS), and Bausch + Lomb (BLCO). These companies are all part of the "medical" sector.

Penumbra vs. Its Competitors

Lantheus (NASDAQ:LNTH) and Penumbra (NYSE:PEN) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, media sentiment, profitability, dividends, risk and analyst recommendations.

Lantheus has a net margin of 16.55% compared to Penumbra's net margin of 11.54%. Lantheus' return on equity of 36.99% beat Penumbra's return on equity.

Company Net Margins Return on Equity Return on Assets
Lantheus16.55% 36.99% 20.55%
Penumbra 11.54%11.55%8.76%

Lantheus currently has a consensus price target of $131.20, suggesting a potential upside of 80.64%. Penumbra has a consensus price target of $300.47, suggesting a potential upside of 25.39%. Given Lantheus' higher probable upside, equities analysts plainly believe Lantheus is more favorable than Penumbra.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lantheus
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
Penumbra
0 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
2 Strong Buy rating(s)
2.94

99.1% of Lantheus shares are held by institutional investors. Comparatively, 88.9% of Penumbra shares are held by institutional investors. 2.0% of Lantheus shares are held by insiders. Comparatively, 5.0% of Penumbra shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Penumbra had 22 more articles in the media than Lantheus. MarketBeat recorded 46 mentions for Penumbra and 24 mentions for Lantheus. Lantheus' average media sentiment score of 0.94 beat Penumbra's score of 0.56 indicating that Lantheus is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Lantheus
15 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Penumbra
15 Very Positive mention(s)
6 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive

Lantheus has higher revenue and earnings than Penumbra. Lantheus is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lantheus$1.53B3.28$312.44M$3.5220.63
Penumbra$1.28B7.30$14.01M$3.7663.73

Lantheus has a beta of 0.14, indicating that its stock price is 86% less volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500.

Summary

Penumbra beats Lantheus on 9 of the 17 factors compared between the two stocks.

Get Penumbra News Delivered to You Automatically

Sign up to receive the latest news and ratings for PEN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PEN vs. The Competition

MetricPenumbraMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$9.35B$6.74B$5.54B$20.58B
Dividend YieldN/A1.31%4.73%3.69%
P/E Ratio63.7321.1428.9629.45
Price / Sales7.3053.67374.6974.44
Price / Cash84.1920.8324.4817.52
Price / Book7.994.708.644.62
Net Income$14.01M$176.39M$3.24B$993.83M
7 Day Performance5.44%-1.82%0.39%-0.87%
1 Month Performance-4.35%-3.03%8.20%0.36%
1 Year Performance34.96%14.32%30.15%16.75%

Penumbra Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PEN
Penumbra
4.8631 of 5 stars
$239.63
-0.3%
$300.47
+25.4%
+37.1%$9.35B$1.28B63.734,500Earnings Report
Analyst Downgrade
LNTH
Lantheus
4.6802 of 5 stars
$72.41
-0.7%
$131.20
+81.2%
-26.8%$5.01B$1.54B20.57700News Coverage
Upcoming Earnings
ITGR
Integer
3.3923 of 5 stars
$108.02
-0.5%
$140.25
+29.8%
-4.3%$3.77B$1.79B47.5911,000
GEHC
GE HealthCare Technologies
4.335 of 5 stars
$77.74
+0.2%
$88.55
+13.9%
-15.3%$35.60B$19.67B16.3753,000Positive News
Earnings Report
PHG
Koninklijke Philips
3.6656 of 5 stars
$25.65
-1.9%
N/A-6.2%$24.70B$19.50B59.6566,678Earnings Report
Analyst Downgrade
ZBH
Zimmer Biomet
4.6528 of 5 stars
$95.94
-1.7%
$111.39
+16.1%
-16.2%$18.98B$7.70B21.2317,000News Coverage
Positive News
Upcoming Earnings
SNN
Smith & Nephew SNATS
3.0935 of 5 stars
$31.19
-1.5%
$28.00
-10.2%
+1.1%$13.66B$5.81B14.4417,349News Coverage
Positive News
Gap Up
SOLV
Solventum
1.3692 of 5 stars
$73.80
-1.3%
$84.38
+14.3%
+27.8%$12.77B$8.31B34.1722,000News Coverage
Positive News
Upcoming Earnings
STVN
Stevanato Group
2.4189 of 5 stars
€25.77
-2.8%
N/A+33.2%€7.80B€1.19B50.535,521News Coverage
GKOS
Glaukos
3.9868 of 5 stars
$94.80
+0.5%
$134.67
+42.1%
-24.6%$5.42B$383.48M-40.00780Earnings Report
BLCO
Bausch + Lomb
2.0536 of 5 stars
$14.47
+1.0%
$15.45
+6.8%
-15.7%$5.12B$4.79B-14.0513,500Earnings Report

Related Companies and Tools


This page (NYSE:PEN) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners